e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Photodynamic therapy (PDT) for the prevention of lung cancer (The Pearl Trial).
G. Hardavella (London, United Kingdom)
Source:
International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Session:
Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Session type:
Thematic Poster
Number:
4281
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Hardavella (London, United Kingdom). Photodynamic therapy (PDT) for the prevention of lung cancer (The Pearl Trial).. 4281
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Related content which might interest you:
Effectiveness of photodynamic therapy (PDT) in lung cancer treatment
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009
Photodynamic therapy (PDT) for in-situ (CIS) and micro-invasive (MCI) lungs cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 492s
Year: 2004
Photodynamic therapy (PDT) in lung cancer with disease limited to endobronchial lesions
Source: Eur Respir J 2004; 24: Suppl. 48, 699s
Year: 2004
Safety analysis of anti-VEGF therapy bevacizumab (Bv) in patients (pts) with untreated advanced non-small cell lung cancer (NSCLC) in MO19390 (SAiL) trial
Source: Annual Congress 2008 - Therapy in thoracic oncology
Year: 2008
Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers
Source: Eur Respir J 2006; 28: 200-218
Year: 2006
Photodynamic therapy using methylene blue in lung cancer animal models
Source: Annual Congress 2013 –Therapeutical bronchoscopy for treatment of airway disorders: laser, stents and more
Year: 2013
Regional laser centre experience in bronchoscopic photodynamic therapy (PDT) in inoperable bronchopulmonary cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 595s
Year: 2002
Efficacy of next treatment received after Nivolumab (Nivo) progression in patients (pts) with non-small-cell lung cancer (NSCLC).
Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies
Year: 2017
Is bronchoscopic photodynamic therapy a therapeutic option in lung cancer?
Source: Eur Respir J 2003; 22: 535-541
Year: 2003
Early stage nonsmall-cell lung cancer: therapeutic options (surgery, adjuvant and neoadjuvant therapy)
Source: Annual Congress 2011 - PG10 Management of thoracic tumours in practice: a HERMES basic course
Year: 2011
Gene therapy with DDMC-p53 with or without cisplatin and microwave ablation. A future concept for local treatment in lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Efficiency of erythropoiesis-stimulating agents (ESA) in the treatment of chemotherapy-induced anemia in patients with lung cancer (LC)
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015
A phase III trial comparing concomitant radiochemotherapy (RT-CT) with cisplatin (P) and docetaxel (D) as induction versus consolidation in patients with locally advanced unresectable non-small cell lung cancer (NSCLC). An ELCWP study
Source: International Congress 2015 – Advances in the therapy of lung cancer
Year: 2015
Ifosfamide (IFO) is a valuable alternative to cisplatin (CDDP) for first-line chemotherapy (CT) in advanced non-small cell lung cancer (NSCLC): A meta-analysis
Source: Annual Congress 2013 –Advances in the therapy of lung cancer
Year: 2013
Docetaxel (DOC) and gemcitabine (GEM) consist a safe and effective combination in the management of non-small cell lung cancer (NSCLC)
Source: Eur Respir J 2003; 22: Suppl. 45, 30s
Year: 2003
Efficacy and safety of full oral vinorelbine (NVBO) on D1 and D8 with carboplatin (CBDCA) as first line treatment in advanced non-small lung cancer (NSCLC) patients: Results of a prospective study in nonrandomized population of 259 patients
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013
Afatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung: LUX-Lung 8 (LL8), a phase III trial
Source: International Congress 2015 – Advances in the therapy of lung cancer
Year: 2015
Interleukin 27 (IL27) as a novel therapeutic tool in lung cancer immune therapy
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013
Site of first progression (PR) differs between stage III NSCLC patients treated with simultaneous radiochemotherapy (RTCT) and those treated with radiotherapy (RT) alone following induction chemotherapy (CT)
Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours
Year: 2014
Efficacy and safety of amurubicin (AMR) for the elderly with refractory relapse small cell lung cancer (SCLC) who had previous treatment
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept